Sex Differences in Complex Regional Pain Syndrome Type I (CRPS-I) in Mice
Overview
Authors
Affiliations
Background: Sex differences have been increasingly highlighted in complex regional pain syndrome (CRPS) in clinical practice. In CRPS type I (CRPS-I), although inflammation and oxidative stress have been implicated in its pathogenesis, whether pain behavior and the underlying mechanism are sex-specific is unclear. In the present study, we sought to explore whether sex differences have an impact on inflammation, oxidative stress, and pain sensitivity in CRPS-I.
Methods: Chronic post-ischemia pain (CPIP) was established in both male and female mice as an animal model of CRPS-I. Edema and mechanical allodynia of bilateral hind paws were assessed after reperfusion. Blood samples were analyzed for serum levels of oxidative stress markers and inflammatory cytokines.
Results: Both male and female mice developed edema. Male mice developed CPIP at day 3 after reperfusion; female mice developed CPIP at day 2 after reperfusion. Female mice displayed significantly earlier and higher mechanical allodynia in the ischemic hind paw, which was associated with higher serum levels of IL-2, TNF-α, isoprostanes, 8 OhdG, and malondialdehyde at day 2 after reperfusion. Moreover, female mice showed significantly lower SOD and IL-4 compared to male mice at day 2 after reperfusion.
Conclusion: Our results indicate that sex differences in inflammatory and oxidative stress states may play a central role in the sex-specific nociceptive hypersensitivity in CRPS-I, and offer a new insight into pharmacology treatments to improve pain management with CRPS.
Mosharaf M, Alam K, Gow J, Mahumud R Sci Rep. 2025; 15(1):7830.
PMID: 40050293 PMC: 11885470. DOI: 10.1038/s41598-024-82992-6.
Accumulating the key proteomic signatures associated with delirium: Evidence from systematic review.
Mosharaf M, Alam K, Gow J, Mahumud R PLoS One. 2024; 19(12):e0309827.
PMID: 39700095 PMC: 11658594. DOI: 10.1371/journal.pone.0309827.
Glutamatergic systems in neuropathic pain and emerging non-opioid therapies.
Temmermand R, Barrett J, Fontana A Pharmacol Res. 2022; 185:106492.
PMID: 36228868 PMC: 10413816. DOI: 10.1016/j.phrs.2022.106492.
Cavalli J, Mendonca de Assis P, Cristina Dalazen Goncalves E, Bobermin L, Quincozes-Santos A, Rezende Barbosa Raposo N Mol Neurobiol. 2022; 59(7):4436-4452.
PMID: 35570263 DOI: 10.1007/s12035-022-02864-w.
Fernandes P, de Oliveira Galassi T, Horewicz V, Salgado A, Mack J, Baldanca H Front Integr Neurosci. 2022; 16:818692.
PMID: 35391753 PMC: 8980433. DOI: 10.3389/fnint.2022.818692.